Secondary cancers after intensity-modulated radiotherapy, brachytherapy and radical prostatectomy for the treatment of prostate cancer: Incidence and cause-specific survival outcomes according to the initial treatment intervention

BJU International

Volumn 110, Issue 11, 2012, Pages 1696-1701

  Zelefsky, Michael J ^a   Pei, Xin ^a   Teslova, Tatiana ^a   Kuk, Deborah ^a   Magsanoc, Juan Martin ^a   Kollmeier, Marisa ^a   Cox, Brett ^a   Zhang, Zhigang ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

brachytherapy; external beam radiotherapy; prostate cancer; secondary cancers

Indexed keywords

IODINE 125; IRIDIUM 192;

ADULT; AGE; AGED; ARTICLE; BLADDER CANCER; BRACHYTHERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CAUSE SPECIFIC SURVIVAL; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LIVER CANCER; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MELANOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RECTUM CANCER; SECOND CANCER; SMOKING; STOMACH CANCER;

EID: 84870897471     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11385.x     Document Type: Article

References (15)

1. Chrouser K, Leibovich B, Bergstralh E, Zincke H, Blute M,. Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer. J Urol 2005; 174: 107-10; discussion 110-1
2. Neugut AI, Ahsan H, Robinson E, Ennis RD,. Bladder carcinoma and other second malignancies after radiotherapy for prostate carcinoma. Cancer 1997; 79: 1600-4
3. Baxter NN, Tepper JE, Durham SB, Rothenberger DA, Virnig BA,. Increased risk of rectal cancer after prostate radiation: a population-based study. Gastroenterology 2005; 128: 819-24
4. Boorjian S, Cowan JE, Konety BR, et al,. Bladder cancer incidence and risk factors in men with prostate cancer: results from Cancer of the Prostate Strategic Urologic Research Endeavor. J Urol 2007; 177: 883-7; discussion 887-8
5. Singh A, Kinoshita Y, Rovito PM Jr, et al,. Higher than expected association of clinical prostate and bladder cancers. J Urol 2005; 173: 1526-9
6. Brenner DJ, Curtis RE, Hall EJ, Ron E,. Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer 2000; 88: 398-406
7. Zelefsky MJ, Yamada Y, Cohen GN, et al,. Five-year outcome of intraoperative conformal permanent I-125 interstitial implantation for patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 2007; 67: 65-70
8. Zelefsky MJ, Chan H, Hunt M, Yamada Y, Shippy AM, Amols H,. Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer. J Urol 2006; 176: 1415-9
9. Kaplan E, Meier P,. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81
10. Gray R,. A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988; 16: 1141-54
11. Herr HW, Carver B,. Point: effect of radiation-associated second malignancies on prostate cancer survival. Urology 2008; 72: 968-70
12. Zelefsky MJ, Housman DM, Pei X, et al,. Incidence of Secondary Cancer Development After High-Dose Intensity-Modulated Radiotherapy and Image-Guided Brachytherapy for the Treatment of Localized Prostate Cancer. Int J Radiat Oncol Biol Phys 2012; 83: 953-9
13. Hinnen KA, Schaapveld M, van Vulpen M, et al,. Prostate brachytherapy and second primary cancer risk: a competitive risk analysis. J Clin Oncol 2011; 29: 4510-5
14. Bhojani N, Capitanio U, Suardi N, et al,. The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17 845 patients. Int J Radiat Oncol Biol Phys 2010; 76: 342-8
15. Huang J, Kestin LL, Ye H, Wallace M, Martinez AA, Vicini FA,. Analysis of second malignancies after modern radiotherapy versus prostatectomy for localized prostate cancer. Radiother Oncol 2011; 98: 81-6